- Walgreens all systems go for 2013; reports 4Q, annual sales
- Super PBM merger approved; NACDS, NCPA file emergency motion to block merger
- Merlo: CVS Caremark positioned to 'effectively compete' in PBM industry
- CVS Caremark discusses WAG-Express Scripts impasse, narrower networks during Morgan Stanley event
- Strong 3Q, ability to retain ESI patients, finds CVS Caremark execs bullish
ST. LOUIS — In an amendment dated Nov. 7 and filed to the Securities Exchange Commission on Tuesday, Express Scripts reduced its termination fee by 32% to $650 million. The termination fee is paid to one company when the other terminates the merger agreement.
The change was made to settle lawsuits against Medco accusing the company of selling itself too cheaply to Express Scripts, according to a research note by Bank of America Merrill Lynch analysts published on Tuesday, as reported by the New York Times. The lower fee may create more interest among rivals hoping to compete for Medco, the analysis concluded.